Merck to Acquire Bio-Techne for $11.3 Billion, Further Concentrating the Life Sciences Tools Landscape
From multiomics and spatial biology to cell and gene therapy manufacturing workflows, the deal shows that major suppliers are consolidating research tools, diagnostics, and bioprocessing capabilities into more complete platforms.